Survey of resistance of herpes simplex virus to acyclovir in northwest England

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 868-872

  Christophers, Jacqueline ^a   Clayton, Julie ^a   Craske, John ^a   Ward, Rosemary ^a   Collins, Peter ^b   Trowbridge, Martin ^b   Darby, Graham ^b  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ARTICLE; DRUG RESISTANCE; GENITAL HERPES; HERPES SIMPLEX VIRUS; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0031977160     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.868     Document Type: Article

References (21)

1. Baker, D. A. (ed.). 1990. Acyclovir therapy for herpesvirus infections. Dekker Publications, New York, N.Y.
2. Collins, P., and G. Darby. 1991. Laboratory studies of herpes simplex virus strains resistant to acyclovir. Rev. Med. Virol. 1:19-28.
3. Collins, P., and N. M. Ellis. 1993. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J. Med. Virol. Suppl. 1:58-66.
4. Collins, P., B. A. Larder, N. M. Oliver, S. Kemp, I. W. Smith, and G. Darby. 1989. Characterisation of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J. Gen. Virol. 70:375-382.
5. Collins, P., and N. M. Oliver. 1986. Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. J. Antimicrob. Chemother. 18(Suppl. B):103-112.
6. Darby, G., H. J. Field, and S. A. Salisbury. 1981. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir resistance. Nature 289:81-83.
7. Efstathiou, S., S. Kemp, G. Darby, and A. C. Minson. 1989. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70:869-879.
8. Ellis, M. N., P. M. Keller, J. A. Fyfe, J. L. Martin, J. F. Rooney, S. E. Straus, S. Nusinoff-Lehrman, and D. W. Barry. 1987. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob. Agents Chemother. 31:1117-1125.
9. England, J. A., M. E. Zimmerman, E. M. Swierkosz, J. L. Goodman, D. R. Scholl, and H. H. Balfour. 1990. Herpes simplex virus resistance to acyclovir. A study in a tertiary care center. Ann. Intern. Med. 112:416-422.
10. Erlich, K. S., J. Mills, P. Chatis, G. J. Mertz, D. F. Busch, S. E. Follansbee, R. M. Grant, and C. S. Crumpacker. 1989. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 320:293-296.
11. Field, H. J., and P. Wildy. 1978. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hyg. 81:267-277.
12. Gray, J. J., T. G. Wreghitt, and T. P. Baglin. 1989. Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia. J. Infect. 19:31-40.
13. Klemperer, H. G., G. R. Haynes, W. I. H. Shedden, and D. H. Watson. 1967. A virus specific thymidine kinase in BHK21 cells infected with herpes sim-plex virus. Virology 31:120-128.
14. Kost, R. G., E. L. Hill, M. Tigges, and S. E. Straus. 1993. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N. Engl. J. Med. 329:1777-1781.
15. Larder, B. A., D. Derse, Y.-C. Cheng, and G. Darby. 1983. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus: evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase. J. Biol. Chem. 258:2027-2033.
16. Larder, B. A., and G. Darby. 1984. Virus drug-resistance: mechanisms and consequences. Antivir. Res. 4:1-42.
17. Larder, B. A., and G. Darby. 1985. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA poiymerase activities. Virology 146:262-271.
18. Martin, J. L., N. M. Ellis, P. M. Keller, K. K. Biron, S. N. Lehrman, D. W. Barry, and P. A. Furman. 1985. Plaque autoradiography assay for the detection and quantitation of thymidine kinase deficient and thymidine kinase altered mutants of herpes simplex virus in clinical isolates. Antimicrob. Agents Chemother. 28:181-187.
19. Safrin, S., E. Tarek, P. Lienhanh, D. Robinson, J. Rush, A. Elbaggari, and J. Mills. 1994. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 38:1246-1250.
20. Vestergard, B. F., and O. Jenson. 1981. Diagnosis and typing of herpes simplex virus in clinical specimens by the enzyme-linked immunosorbent assay (ELISA), p. 391-394. In A. J. Nahmias, W. R. Dowdle, and R. F. Schinazi (ed.). The human herpes viruses. Elsevier, North-Holland Inc., New York, N.Y.
21. Wade, J. C., B. Newton, C. McLaren, N. Flournoy, R. E. Keeney, and J. D. Meyers. 1983. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double blind test. Ann. Intern. Med. 96:265-269.